ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
1,3,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
2,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
3,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
3,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
4,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
4,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
5,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
5,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
5,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
5,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
5,5,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
6,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
6,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
6,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
7,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
7,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
8,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
8,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
8,3,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
8,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
9,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
9,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
9,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
9,5,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
10,1,Drug withdrawal convulsions,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
11,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
11,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
11,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
11,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
13,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
14,1,Anticoagulant therapy,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
14,2,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
14,3,Stent placement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
15,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
15,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
16,1,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
17,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
17,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
18,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
19,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
20,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
20,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
20,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
20,4,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
20,5,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
21,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
21,2,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
21,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
21,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
21,5,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
22,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
22,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
23,1,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
24,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
25,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
25,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
26,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
26,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
26,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
27,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
28,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
29,1,Bladder catheterisation,Therapeutic bladder catheterisation,Renal and urinary tract therapeutic procedures,Surg,N
29,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
29,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
30,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
30,2,Labelled drug-disease interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
31,1,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
31,2,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
32,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
32,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
33,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
34,1,Colour blindness acquired,Colour blindness (incl acquired),Vision disorders,Eye,N
34,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
35,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
36,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
37,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
37,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
37,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
38,1,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
38,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
39,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
40,1,Radiotherapy,Radiotherapies site unspecified,Therapeutic procedures and supportive care NEC,Surg,N
41,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
42,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
42,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
43,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
44,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
44,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
45,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
45,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,Y
45,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
45,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
45,5,Headache,Headaches NEC,Headaches,Nerv,N
45,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
45,7,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
46,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
47,1,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
47,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
48,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
49,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
50,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
51,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
52,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
52,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
53,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
54,1,Depression suicidal,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
55,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
56,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
57,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
58,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
59,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
59,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
59,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
60,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
60,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
61,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
61,2,Bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
61,3,Carpal tunnel syndrome,Mononeuropathies,Peripheral neuropathies,Nerv,N
61,4,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
61,5,Knee arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
61,6,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
61,7,Sensitivity to weather change,General signs and symptoms NEC,General system disorders NEC,Genrl,N
62,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
63,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
64,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
65,1,Cholecystectomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
66,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
66,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
67,1,Candida infection,Candida infections,Fungal infectious disorders,Infec,N
67,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
67,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
67,4,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
67,5,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
67,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,7,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,8,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
68,1,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
69,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
69,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
69,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
69,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
70,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
71,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
71,2,Shoulder operation,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
72,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
72,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
73,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
73,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
74,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
74,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
74,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
75,1,Organ failure,General signs and symptoms NEC,General system disorders NEC,Genrl,N
75,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
76,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
77,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
78,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
79,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
80,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
80,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
81,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
82,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
83,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
84,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
84,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
84,3,Pelvic fracture,Pelvic fractures and dislocations,Bone and joint injuries,Inj&P,N
85,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
86,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
86,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
87,1,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
88,1,Cholelithotomy,Biliary tract and gallbladder therapeutic procedures,Hepatobiliary therapeutic procedures,Surg,N
89,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
90,1,Physiotherapy,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
91,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
91,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
91,4,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
92,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
92,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
93,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
93,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
93,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
93,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
93,5,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
93,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
93,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
93,8,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
94,1,Campylobacter gastroenteritis,Campylobacter infections,Bacterial infectious disorders,Infec,N
95,1,Cystic fibrosis,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,N
95,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
95,3,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
96,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
97,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
98,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
98,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
98,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
99,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
99,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
99,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
100,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
100,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
101,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
102,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
103,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
103,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
103,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
104,1,Headache,Headaches NEC,Headaches,Nerv,N
104,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
104,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
104,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
104,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
105,1,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
106,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
107,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
108,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
108,2,Humerus fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
108,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
108,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
108,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
108,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,7,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
108,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
108,9,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
109,1,Drug delivery device placement,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
110,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
110,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
111,1,Abdominoplasty,Abdominal therapeutic procedures NEC,Gastrointestinal therapeutic procedures,Surg,N
111,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
111,3,Liposuction,Soft tissue therapeutic procedures NEC,Soft tissue therapeutic procedures,Surg,N
111,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
111,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
112,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
112,2,Central nervous system vasculitis,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,Y
112,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
112,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
112,5,Headache,Headaches NEC,Headaches,Nerv,N
112,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
112,7,Red blood cell sedimentation rate increased,Haematological analyses NEC,Haematology investigations (incl blood groups),Inv,N
113,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
113,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
113,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
114,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
114,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
115,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
116,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
116,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
116,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
116,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
117,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
117,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
118,1,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
119,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
120,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
121,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
121,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
122,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
122,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
122,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
123,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
123,2,Dementia,Dementia (excl Alzheimer's type),Mental impairment disorders,Nerv,N
123,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
123,4,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
123,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
123,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
123,7,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
124,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
124,2,Headache,Headaches NEC,Headaches,Nerv,N
124,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
125,1,Bladder irritation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
125,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
126,1,Obstructive pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
126,2,Osteomyelitis,Bone and joint infections,Infections - pathogen unspecified,Infec,N
127,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
127,2,Mechanical ventilation,Respiratory tract therapeutic procedures NEC,Respiratory tract therapeutic procedures,Surg,N
128,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
128,2,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
129,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
130,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
130,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
130,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
130,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
131,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
132,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
133,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
133,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
134,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
134,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
134,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
134,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
134,6,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
134,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
135,1,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
135,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
135,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
135,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
135,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
136,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
136,2,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
137,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
137,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
137,3,Foreign body in throat,Chest and respiratory tract injuries NEC,Injuries NEC,Inj&P,N
137,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
137,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
137,6,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
137,7,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
137,8,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
137,9,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
137,10,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
137,11,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
138,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
139,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
139,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
139,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
139,4,Bipolar disorder,Bipolar disorders,Manic and bipolar mood disorders and disturbances,Psych,N
139,5,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
139,6,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
139,7,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
139,8,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
139,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
139,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
139,11,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
139,12,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
139,13,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
139,14,Initial insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
139,15,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
139,16,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
139,17,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
139,18,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
139,19,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
139,20,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
139,21,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
139,22,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
139,23,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
139,24,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
139,25,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
139,26,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
139,27,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
139,28,Skin laceration,Skin injuries NEC,Injuries NEC,Inj&P,N
139,29,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
139,30,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
140,1,Primary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
141,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
141,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
141,3,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
141,4,Osteonecrosis,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
142,1,Cholelithiasis obstructive,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
142,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
143,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
143,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
143,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
144,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
144,2,Lung neoplasm,Respiratory tract and pleural neoplasms malignancy unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
144,3,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
145,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
146,1,Diplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
146,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
146,3,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
146,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
147,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
147,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
147,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
147,4,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
147,5,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
147,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
147,7,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
147,8,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
148,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
149,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
149,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
149,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
150,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
150,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
150,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
150,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
151,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
151,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
151,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
151,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
152,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
152,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
152,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
152,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
152,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
152,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
153,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
154,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
154,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
154,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
154,4,Noninfective encephalitis,Encephalitis NEC,Central nervous system infections and inflammations,Nerv,N
155,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
155,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
156,1,Abdominal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
157,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
157,2,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
158,1,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
158,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
158,3,Urosepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
159,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
159,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
160,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
161,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
161,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
161,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
161,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
161,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
162,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
162,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
163,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
163,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
164,1,Back injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
164,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
165,1,Cataract,Cataract conditions,"Anterior eye structural change, deposit and degeneration",Eye,N
165,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
165,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
165,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
166,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
166,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
167,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
167,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
167,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
167,4,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
167,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
167,6,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
167,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
167,8,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
167,9,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
167,10,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
167,11,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
167,12,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
167,13,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
168,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
168,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
168,3,Lower urinary tract symptoms,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
168,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
169,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
169,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
169,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
169,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
170,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
171,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
172,1,Intraductal proliferative breast lesion,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
173,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
173,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
174,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
175,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
175,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
176,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
176,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
177,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
177,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
178,1,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
178,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
179,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
179,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
179,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
179,4,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
179,5,Myelitis transverse,Myelitis (incl infective),Central nervous system infections and inflammations,Nerv,N
179,6,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
180,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
180,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
180,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
180,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
180,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
181,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
181,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
181,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
182,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
182,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
182,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
182,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
182,5,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
182,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
183,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
184,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
185,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
185,2,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
185,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
185,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
185,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
185,6,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
185,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
186,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
186,2,Fibula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
186,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
186,4,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
186,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
186,6,Tibia fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
186,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
187,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
188,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
188,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
189,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
189,2,Dermoid cyst,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
189,3,Ovarian disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
190,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
190,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
191,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
191,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
191,3,Fluid intake reduced,Fluid intake decreased,Electrolyte and fluid balance conditions,Metab,N
191,4,Food poisoning,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
191,5,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
191,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
191,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
192,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
193,1,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
193,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
194,1,Terminal state,General signs and symptoms NEC,General system disorders NEC,Genrl,N
195,1,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
196,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
197,1,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
198,1,Aortic disorder,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
198,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
199,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
199,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
199,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
200,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
200,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
200,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
200,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
200,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
200,6,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
200,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
200,8,Micturition disorder,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
200,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
200,10,Urethral stenosis,Structural and obstructive urethral disorders (excl congenital),Urethral disorders (excl calculi),Renal,N
200,11,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
201,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
201,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
202,1,Cartilage injury,Bone and joint injuries NEC,Bone and joint injuries,Inj&P,N
202,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
202,3,Viral upper respiratory tract infection,Viral infections NEC,Viral infectious disorders,Infec,N
203,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
204,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
204,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
204,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
205,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
206,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
207,1,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
208,1,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
208,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
208,3,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
208,4,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
208,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
208,6,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
209,1,Blindness transient,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
209,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
209,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
209,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
209,5,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
210,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
210,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
210,3,Delusional perception,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
210,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
210,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
210,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
210,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
211,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
211,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
211,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
211,4,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
211,5,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
212,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
213,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
213,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
213,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
214,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
214,2,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
214,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
214,4,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
214,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
214,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
215,1,Upper limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
216,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
216,2,Ear infection,Ear infections,Infections - pathogen unspecified,Infec,N
216,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
216,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
216,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
216,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
217,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
217,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
217,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
217,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
218,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
219,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
219,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
220,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
220,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
220,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
221,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
222,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
222,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
223,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
223,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
224,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,Y
225,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
226,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
227,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
228,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
228,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
229,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
229,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
229,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
229,4,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
230,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
230,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
230,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
230,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
231,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
231,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
231,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
232,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
232,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
232,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
232,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
232,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
232,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
232,7,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
233,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
233,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
233,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
234,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
234,2,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
234,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
234,4,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
234,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
234,6,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
234,7,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
234,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
235,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
236,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
236,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
236,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
236,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
236,5,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
237,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
238,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
238,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
238,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
238,4,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
239,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
239,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
239,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
240,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
241,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
241,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
241,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
241,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
241,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
241,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
242,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
242,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
242,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
242,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
242,5,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
242,6,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
242,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
242,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
242,9,Sluggishness,Asthenic conditions,General system disorders NEC,Genrl,N
243,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
243,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
244,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
244,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
245,1,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
245,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
245,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
245,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
245,5,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
246,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
246,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
246,3,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
247,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
247,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
247,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
247,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
248,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
248,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
248,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
248,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
248,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
248,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
249,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
250,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
250,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
251,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
251,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
251,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
252,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
252,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
252,3,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
252,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
252,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
252,6,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
252,7,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
252,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
252,9,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
252,10,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
252,11,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
252,12,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
252,13,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
252,14,Ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
252,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
252,16,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
252,17,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
253,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
253,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
253,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
253,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
253,5,Headache,Headaches NEC,Headaches,Nerv,N
253,6,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
254,1,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
254,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
256,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
256,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
257,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
257,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
257,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
258,1,Volvulus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
259,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
259,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
260,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
260,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
260,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
261,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
262,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
262,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
262,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
263,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
263,2,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
263,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
263,4,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
263,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
263,6,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
263,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
263,8,Onychomadesis,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
263,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
263,10,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
263,11,Spinal column injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
263,12,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
264,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
264,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
264,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
264,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
264,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
264,6,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
265,1,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
266,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
266,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
266,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
266,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
266,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
267,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
267,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
267,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
267,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
267,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
268,1,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
269,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
269,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
269,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
270,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
270,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
270,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
270,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
270,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
270,6,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
270,7,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
270,8,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
270,9,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
270,10,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
270,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
270,12,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
271,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
271,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
272,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
272,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
272,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
272,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
272,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
272,6,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
273,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
273,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
273,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
273,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
273,5,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
273,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
273,7,Muscle rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
273,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
274,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
274,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
275,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
276,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
276,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
276,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
277,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
278,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
279,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
279,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
280,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
280,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
280,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
280,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
280,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
280,6,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
281,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
281,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
281,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
281,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
281,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
281,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
281,7,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
281,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
281,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
281,10,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,11,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
281,12,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
282,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
282,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
282,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
282,4,Psychiatric symptom,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
283,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
285,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
285,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
285,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
286,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
287,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
288,1,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
289,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
290,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
291,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
291,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
291,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
291,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
291,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
291,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
291,7,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
292,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
292,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
293,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
294,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
295,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
295,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
295,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
295,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
295,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
296,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
297,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
297,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
298,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
299,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
299,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
299,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
299,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
299,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
299,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
299,7,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
299,8,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
299,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
299,10,Secondary progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
300,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
300,2,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
300,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
301,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
302,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
303,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
304,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
304,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
304,3,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
305,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
305,2,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
306,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
306,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
307,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
308,1,COVID-19 pneumonia,Coronavirus infections,Viral infectious disorders,Infec,N
309,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
310,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
310,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
311,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
312,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
313,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
313,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
314,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
314,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
315,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
316,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
317,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
317,2,Decreased gait velocity,Gait disturbances,General system disorders NEC,Genrl,N
318,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
318,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
319,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
320,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
320,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
321,1,Lumbar radiculopathy,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
321,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
321,3,Spinal osteoarthritis,Osteoarthropathies,Joint disorders,Musc,N
322,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
322,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
323,1,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
324,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
324,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
325,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
325,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
326,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
326,2,Necrotising fasciitis,Muscle and soft tissue infections,Infections - pathogen unspecified,Infec,N
327,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
328,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
329,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
329,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
329,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
329,4,Shoulder fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
330,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
330,2,Headache,Headaches NEC,Headaches,Nerv,N
330,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
331,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
332,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
332,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
332,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
333,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
334,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
334,2,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
335,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
336,1,Allergy to vaccine,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
336,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
336,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
337,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
338,1,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
338,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
338,3,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
338,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
338,5,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
338,6,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
338,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
338,8,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
338,9,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
339,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
340,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
341,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
342,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
343,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
344,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
345,2,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
345,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
345,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
345,5,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
346,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
346,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
347,1,Foot fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
348,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
348,2,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
349,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
350,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
350,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
351,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
351,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
351,3,Hypertonic bladder,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
351,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
352,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
352,2,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
352,3,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
353,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
354,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
355,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
356,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
357,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
357,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
358,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
359,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
359,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
360,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
360,2,Blood calcium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
360,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
360,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
360,5,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
360,6,Thyroid disorder,Thyroid disorders NEC,Thyroid gland disorders,Endo,N
361,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
361,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
361,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
362,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
363,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
364,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
365,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
366,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
366,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
366,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
367,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
368,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
369,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
370,1,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
370,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
371,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
371,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
371,3,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
371,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
371,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
372,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
373,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
373,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
374,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
374,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
375,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
376,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
377,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
378,1,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
378,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
378,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
379,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
380,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
380,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
381,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
382,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
382,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
382,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
383,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
383,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
383,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
384,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
385,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
385,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
386,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
387,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
388,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
389,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
390,1,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
390,2,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
390,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
391,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
391,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
391,3,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
392,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
392,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
393,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
393,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
393,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
393,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
393,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
393,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
393,7,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
394,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
394,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
395,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
396,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
396,2,Upper respiratory tract congestion,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
397,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
397,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
398,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
398,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
399,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
399,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
399,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
399,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
400,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
401,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
402,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
403,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
403,2,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
404,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
404,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
404,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
405,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
405,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
405,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
406,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
406,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
407,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
408,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
409,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
409,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
410,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
411,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
412,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
412,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
412,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
412,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
413,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
413,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
414,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
414,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
414,3,Hypersomnia,Narcolepsy and hypersomnia,Sleep disturbances (incl subtypes),Nerv,N
414,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
414,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
415,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
415,2,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
415,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
415,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
415,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
415,6,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
415,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
415,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
415,9,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
416,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
416,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
416,3,Oropharyngeal discomfort,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
416,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
416,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
416,6,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
417,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
418,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
418,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
419,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
420,1,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
420,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
421,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
421,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
422,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
423,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
424,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
424,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
424,3,Headache,Headaches NEC,Headaches,Nerv,N
424,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
425,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
426,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
427,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
428,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
429,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
429,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
430,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
430,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
430,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
431,1,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
431,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
431,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
431,4,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
431,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
431,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
431,7,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
431,8,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
432,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
432,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
433,1,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
433,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
434,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
435,1,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
436,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
436,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
437,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
437,2,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
438,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
438,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
438,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
438,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
438,5,Limb injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
438,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
438,7,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
439,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
439,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
440,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
441,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
441,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
441,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
441,4,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
441,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
441,6,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
442,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
443,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
443,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
443,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
443,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
444,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
444,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
444,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
444,4,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
444,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
444,6,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
445,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
446,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
446,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
446,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
446,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
447,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
447,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
448,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
448,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
448,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
449,1,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
449,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
449,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
449,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
449,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
450,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
450,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
451,1,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
451,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
451,3,Headache,Headaches NEC,Headaches,Nerv,N
452,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
453,1,Adverse food reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
454,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
455,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
456,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
456,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
456,3,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
456,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
456,5,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
456,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
457,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
457,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
458,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
458,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
459,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
459,2,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
460,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
460,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
460,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
461,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
462,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
463,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
463,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
463,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
463,4,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
464,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
464,2,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
465,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
465,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
466,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
467,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
467,2,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
468,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
469,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
470,1,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
471,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
472,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
472,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
473,1,Headache,Headaches NEC,Headaches,Nerv,N
474,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
475,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
475,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
476,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
477,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
477,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
477,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
478,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
478,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
479,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
479,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
480,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
481,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
481,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
482,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
483,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
484,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
485,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
485,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
485,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
485,4,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
486,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
486,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
487,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
487,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
487,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
487,4,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
487,5,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
487,6,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
488,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
488,2,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
488,3,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
489,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
490,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
490,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
490,3,Headache,Headaches NEC,Headaches,Nerv,N
491,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
491,2,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
492,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
492,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
492,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
493,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
493,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
494,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
494,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
494,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
495,1,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
496,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
497,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
497,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
497,3,Headache,Headaches NEC,Headaches,Nerv,N
498,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
498,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
499,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
499,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
499,3,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
500,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
500,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
500,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
500,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
501,1,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
501,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
501,3,Posture abnormal,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
502,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
502,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
502,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
502,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
502,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
503,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
504,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
505,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
505,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
505,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
506,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
506,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
507,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
507,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
507,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
507,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
507,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
507,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
508,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
509,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
509,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
509,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
509,4,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
509,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
509,6,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
510,1,Crohn's disease,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
510,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
511,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
512,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
513,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
514,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
514,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
514,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
515,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
516,1,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
517,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
518,1,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
519,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
520,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
520,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
520,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
520,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
520,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
520,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
520,7,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
520,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
520,9,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
521,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
522,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
522,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
523,1,Headache,Headaches NEC,Headaches,Nerv,N
524,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
525,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
526,1,Extremity contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
526,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
526,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
526,4,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
526,5,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
526,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
527,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
528,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
528,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
529,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
529,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
529,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
530,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
531,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
531,2,Headache,Headaches NEC,Headaches,Nerv,N
532,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
532,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
532,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
532,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
533,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
534,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
535,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
535,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
536,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
536,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
536,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
537,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
538,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
538,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
539,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
540,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
541,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
542,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
542,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
543,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
543,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
544,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
545,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
545,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
545,3,Initial insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
545,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
545,5,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
546,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
546,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
547,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
548,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
549,1,Decubitus ulcer,Skin injuries and mechanical dermatoses,Epidermal and dermal conditions,Skin,N
549,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
549,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
549,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
550,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
550,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
550,3,Headache,Headaches NEC,Headaches,Nerv,N
550,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
550,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
550,6,Middle insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
550,7,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
550,8,Procedural pain,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
551,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
551,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
552,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
553,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
553,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
553,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
554,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
555,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
556,1,Migraine,Migraine headaches,Headaches,Nerv,N
557,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
558,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
558,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
558,3,Headache,Headaches NEC,Headaches,Nerv,N
558,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
558,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
559,1,Delirium,Deliria,Deliria (incl confusion),Psych,N
559,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
559,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
559,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
559,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
559,6,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
559,7,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
560,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
560,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
560,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
560,4,Feeling drunk,Feelings and sensations NEC,General system disorders NEC,Genrl,N
560,5,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
560,6,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
560,7,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
560,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
560,9,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
561,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
561,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
561,3,Fractured sacrum,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
561,4,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
561,5,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
561,6,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
561,7,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
561,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
562,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
562,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
563,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
563,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
564,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
564,2,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
565,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
565,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
566,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
566,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
566,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
567,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
567,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
567,3,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
567,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
567,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
568,1,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
568,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
569,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
569,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
570,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
571,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
571,2,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
571,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
571,4,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
571,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
572,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
573,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
574,1,Fine motor skill dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
574,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
574,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
574,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
575,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
575,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
576,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
576,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
576,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
576,4,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
576,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
577,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
577,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
577,3,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
578,1,Headache,Headaches NEC,Headaches,Nerv,N
578,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
579,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
580,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
580,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
581,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
581,2,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
582,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
583,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
583,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
584,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
585,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
586,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
586,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
586,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
587,1,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
588,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
589,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
589,2,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
590,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
591,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
592,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
592,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
593,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
594,1,Cheilitis,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
594,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
595,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
595,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
596,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
596,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
597,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
598,1,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
599,1,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
599,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
600,1,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
601,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
601,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
602,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
603,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
604,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
605,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
605,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
605,3,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
605,4,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
605,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
605,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
606,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
606,2,Headache,Headaches NEC,Headaches,Nerv,N
606,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
607,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
608,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
609,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
610,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
610,2,Migraine,Migraine headaches,Headaches,Nerv,N
611,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
611,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
612,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
613,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
613,2,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
613,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
613,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
614,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
615,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
616,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
617,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
617,2,Headache,Headaches NEC,Headaches,Nerv,N
617,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
617,4,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
618,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
618,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
618,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
619,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
620,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
620,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
621,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
622,1,Gastrointestinal infection,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
623,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
623,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
623,3,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
624,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
624,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
625,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
625,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
625,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
626,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
626,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
627,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
628,1,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
629,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
629,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
629,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
629,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
629,5,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
629,6,Dental discomfort,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
629,7,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
629,8,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
629,9,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
629,10,Gingival discomfort,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
629,11,Headache,Headaches NEC,Headaches,Nerv,N
629,12,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
629,13,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
629,14,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
629,15,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
629,16,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
629,17,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
629,18,Rhinitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
629,19,Secretion discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
629,20,Sinus disorder,Paranasal sinus disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
629,21,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
629,22,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
629,23,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
629,24,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
630,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
630,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
630,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
630,4,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
631,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
631,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
632,1,Salivary gland calculus,Salivary gland disorders NEC,Salivary gland conditions,Gastr,N
632,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
632,3,Tonsillar disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
633,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
633,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
633,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
633,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
634,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
634,2,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
634,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
635,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
635,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
635,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
636,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
637,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
637,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
637,3,SARS-CoV-2 test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
638,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
639,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
639,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
639,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
639,4,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
639,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
639,6,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
639,7,Ligament sprain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
639,8,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
639,9,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
639,10,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
639,11,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
640,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
641,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
641,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
642,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
642,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
643,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
643,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
644,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
645,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
645,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
646,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
647,1,Lumbar vertebral fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
648,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
649,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
649,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
650,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
650,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
650,3,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
651,1,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
652,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
652,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
652,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
653,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
653,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
653,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
653,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
653,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
653,6,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
654,1,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
654,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
654,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
655,1,Decreased gait velocity,Gait disturbances,General system disorders NEC,Genrl,N
655,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
655,3,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
655,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
656,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
657,1,Pneumonia influenzal,Influenza viral infections,Viral infectious disorders,Infec,N
658,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
658,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
659,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
659,2,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
660,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
660,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
661,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
661,2,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
661,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
662,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
663,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
663,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
664,1,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
665,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
665,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
665,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
665,4,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
666,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
667,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
668,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
668,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
668,3,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
668,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
669,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
669,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
670,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
671,1,Hepatic infection,Hepatobiliary and spleen infections,Infections - pathogen unspecified,Infec,N
671,2,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
671,3,Kidney infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
671,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
672,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
672,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
672,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
672,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
673,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
673,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
674,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
674,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
674,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
675,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
676,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
677,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
678,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
679,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
680,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
680,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
680,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
680,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
680,5,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
681,1,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
681,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
682,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
683,1,Neoplasm,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
684,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
684,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
685,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
685,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
686,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
687,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
688,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
689,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
689,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
689,3,Headache,Headaches NEC,Headaches,Nerv,N
690,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
690,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
691,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
691,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
692,1,Ankle fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
692,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
692,3,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
693,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
694,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
695,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
695,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
695,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
696,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
697,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
697,2,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
698,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
698,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
698,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
699,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
699,2,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
700,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
701,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
701,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
702,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
703,2,Motor dysfunction,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
704,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
705,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
705,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
705,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
706,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
707,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
708,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
709,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
710,1,Immunisation reaction,Vaccination related complications,Procedural related injuries and complications NEC,Inj&P,N
711,1,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
712,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
713,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
713,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
714,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
715,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
716,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
717,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
718,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
719,1,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
719,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
719,3,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
719,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
719,5,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
720,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
721,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
722,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
722,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
723,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
724,1,Headache,Headaches NEC,Headaches,Nerv,N
725,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
725,2,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
725,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
725,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
726,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
727,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
727,2,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
727,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
728,1,Bradykinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
729,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
729,2,Headache,Headaches NEC,Headaches,Nerv,N
729,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
730,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
731,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
732,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
733,1,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
734,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
734,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
735,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
736,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
737,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
738,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
739,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
740,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
740,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
740,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
740,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
741,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
741,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
741,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
741,4,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
742,1,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
743,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
744,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
745,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
746,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
747,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
748,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
748,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
748,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
749,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
749,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
749,3,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
750,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
751,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
752,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
752,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
753,1,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
754,1,Headache,Headaches NEC,Headaches,Nerv,N
754,2,Trigeminal neuralgia,Trigeminal disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
754,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
754,4,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
754,5,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
755,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
756,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
756,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
757,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
758,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
759,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
759,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
760,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
760,2,Gastroenteritis viral,Viral infections NEC,Viral infectious disorders,Infec,N
761,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
762,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
762,2,Intentional underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
763,1,Tuberculosis,Tuberculous infections,Mycobacterial infectious disorders,Infec,N
764,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
765,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
765,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
765,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
766,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
766,2,Headache,Headaches NEC,Headaches,Nerv,N
766,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
767,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
768,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
769,1,Progressive multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
770,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
770,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
771,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
772,1,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
773,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
773,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
773,3,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
774,1,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
774,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
775,1,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
776,1,Eye injury,Eye injuries NEC,Injuries NEC,Inj&P,N
776,2,Scapula fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
776,3,Sternal fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
776,4,Tooth injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
777,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
778,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
779,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
779,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
779,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
780,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
781,1,Arthropathy,Arthropathies NEC,Joint disorders,Musc,N
781,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
781,3,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
782,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
782,2,Respiratory rate decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
783,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
783,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
783,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
783,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
783,5,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
784,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
785,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
785,2,Loss of control of legs,Gait disturbances,General system disorders NEC,Genrl,N
785,3,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
786,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
787,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
788,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
789,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
790,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
790,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
791,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
792,1,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
793,1,Device issue,Device issues NEC,Device issues,Prod,N
794,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
795,1,Abdominal hernia,Abdominal hernias NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
795,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
795,3,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
796,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
796,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
796,3,Headache,Headaches NEC,Headaches,Nerv,N
797,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
797,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
797,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
798,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
799,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
799,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
799,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
799,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
799,5,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
799,6,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
799,7,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
800,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
801,1,Impaired healing,Healing abnormal NEC,Tissue disorders NEC,Genrl,N
801,2,Lower limb fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
802,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
803,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
804,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
804,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
805,1,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
805,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
805,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
806,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
806,2,Foot deformity,Extremity deformities,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
807,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
807,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
808,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
809,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
810,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
810,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
811,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
812,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
812,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
812,3,Hand fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
812,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
812,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
812,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
813,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
814,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
814,2,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
815,1,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
816,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
816,2,Intervertebral disc protrusion,Intervertebral disc disorders NEC,Musculoskeletal and connective tissue deformities (incl intervertebral disc disorders),Musc,N
817,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
817,2,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
818,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
818,2,Headache,Headaches NEC,Headaches,Nerv,N
818,3,Injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
818,4,Lip injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
818,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
818,6,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
819,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
819,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
819,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
819,4,Tooth fracture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
820,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
821,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
821,2,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
822,1,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
823,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
823,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
824,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
825,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
825,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
825,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
825,4,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
826,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
826,2,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
826,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
826,4,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
827,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
827,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
828,1,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
828,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
828,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
829,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
830,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
830,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
831,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
831,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
832,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
832,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
833,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
833,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
834,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
835,1,Multiple sclerosis relapse,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
836,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
836,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
836,3,Tension headache,Headaches NEC,Headaches,Nerv,N
837,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
837,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
838,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
838,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
838,3,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
839,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
840,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
841,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
841,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
842,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
843,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
844,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
845,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
846,1,Multiple sclerosis,Multiple sclerosis acute and progressive,Demyelinating disorders,Nerv,N
846,2,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
847,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
847,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
848,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
848,2,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
848,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
848,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
848,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
849,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
850,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
851,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
852,1,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
852,2,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
852,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
852,4,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
853,1,Migraine,Migraine headaches,Headaches,Nerv,N
854,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
854,2,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
854,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
854,4,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
854,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
855,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
855,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
855,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
856,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
856,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
857,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
858,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
858,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
858,3,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
858,4,Slow speech,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
859,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
859,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
860,1,Headache,Headaches NEC,Headaches,Nerv,N
861,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
862,1,Gait disturbance,Gait disturbances,General system disorders NEC,Genrl,N
863,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
864,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
864,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
865,1,Decreased activity,Asthenic conditions,General system disorders NEC,Genrl,N
865,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
866,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
867,1,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
868,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
869,1,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
870,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
870,2,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
870,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
871,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
871,2,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
872,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
873,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
873,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
874,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
875,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
875,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
875,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
875,4,Intentional dose omission,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
875,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
875,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
876,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
877,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
877,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
877,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
878,1,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
879,1,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
